Delivery Order SPE2DB22D2007-SPE2DB25FJ5LK
- Not listed
- The U.S. Defense Department's Medical Supply Chain awarded a $4,923.54 delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Oxcarbazepine ER 600 mg tablets (100-count units). This firm fixed-price, non-set-aside contract is scheduled for ultimate completion by July 28, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child delivery order under a larger contract vehicle,...
- This is a federal contract award made by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,048.26, is for the delivery of 100 tablets of Oxcarbazepine ER 150 mg, a medication used to treat seizures. This is a Firm Fixed Price Delivery Order contract, with an ultimate completion date of January 24, 2025. The contract was awarded on January 23, 2025, and was not...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Oxcarbazepine ER 600 mg tablets (100-count packaging) under a firm fixed-price contract valued at $7,215.32. The award, which must be completed by September 18, 2025, represents a competitive procurement with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The order, valued at $3,890.30, is for the supply of 4,558,996,119 Oxcarbazepine 300 mg tablets. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. The IDC, valued at up to $999,999,999.00, serves as the...
- Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, has been awarded a $360,840 delivery order by the Defense Logistics Agency to supply 600 mg oxcarbazepine tablets. The firm fixed price order is for 100 count bottles of the pharmaceutical and will be fulfilled from Amerisourcebergen's facility in Conshohocken, Pennsylvania by August 10, 2023. No subcontractors or set aside designations were identified. The Defense Logistics Agency routinely issues delivery orders...
- Amerisourcebergen Drug Corporation, a subsidiary of Amerisourcebergen Corporation, has been awarded a delivery order valued at $237.10 by the Defense Logistics Agency to provide 300mg tablets of Oxcarbazepine in quantities of 100 tablets per unit. The order is to be fulfilled from Amerisourcebergen's facility in Conshohocken, Pennsylvania between August 11-14, 2023. No major subcontractors or set aside designations were indicated. This order is part of the Defense Logistics Agency's portfolio of...
- Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, has been awarded a delivery order valued at approximately $217,000 by the Defense Logistics Agency to provide Oxcarbazepine 600 mg tablets. The firm fixed price order is for 100 count bottles of the pharmaceutical and will be fulfilled from Amerisourcebergen's facility in Conshohocken, Pennsylvania by August 14, 2023. No subcontractors or set aside designations were indicated. This support for branded and generic...
- Amerisourcebergen Drug Corporation, operating as Amerisourcebergen, has been awarded a $17,150 firm fixed price delivery order by the Defense Logistics Agency Troop Support Medical to supply 100 count packages of 300mg Oxcarbazepine tablets. The single day contract is to be performed in Conshohocken, Pennsylvania under the agency's indefinite-delivery/indefinite-quantity prime vendor program, which provides pharmaceuticals and other medical supplies to support the Department of Defense. No...
- Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, has been awarded a $51,450 firm fixed price delivery order by the Defense Logistics Agency to provide 100 tablets of 300mg Oxcarbazepine for use by the Department of Defense. The single day contract issued on August 15, 2023 has a period of performance through August 16, 2023 with all products to be delivered from Amerisourcebergen's facility in Conshohocken, Pennsylvania. No subcontractors or set aside designations...
- Amerisourcebergen Drug Corporation, a subsidiary of Amerisourcebergen Corporation, has been awarded a $226,730 delivery order by the Defense Logistics Agency to supply 100 count bottles of the generic pharmaceutical Oxcarbazepine 300mg tablets. Performance will take place at Amerisourcebergen's facility in Conshohocken, Pennsylvania under a firm fixed price contract spanning September 1st through 5th, 2023. No subcontractors or set aside designations were identified. The Defense Logistics Agency...
- SPE2DB22D2007Indefinite Delivery Contract
- SPE2DB22D2007-SPE2DB25FJ5LKDelivery Order
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order by the Defense Logistics Agency (DLA) for Oxcarbazepine ER 600 mg tablets (100-count) with a ceiling value of $4,263.61. This competitively awarded, firm fixed-price contract has no set-aside designation and is scheduled for completion by September 30, 2025. The award represents a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military and federal healthcare systems. Oxcarbazepine is a neurological medication commonly used to treat seizure disorders and neuropathic pain conditions. Through the SPE2DX prime vendor contract, AmerisourceBergen supplies a broad portfolio of pharmaceutical products and medical commodities to support Defense Health Agency operations and other federal healthcare customers worldwide. The company's contract awards demonstrate its established capability to fulfill federal medical procurement requirements across diverse therapeutic domains, ranging from specialty medications to vaccines and medical supplies, positioning it as a critical vendor within the military medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.3k | 9/29/25 |